UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

The lancet oncology, 2017, Vol.18 (1), p.63-74

2017

Volltextzugriff (PDF)

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors

JNCI : Journal of the National Cancer Institute, 2014-08, Vol.106 (8), p.dju186-dju186

2014

Volltextzugriff (PDF)

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Blood, 2014-10, Vol.124 (15), p.2400-2407

2014

Volltextzugriff (PDF)

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Blood, 2008-02, Vol.111 (3), p.1044-1053

2008

Volltextzugriff (PDF)

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

Blood, 2007-11, Vol.110 (10), p.3532-3539

2007

Volltextzugriff (PDF)

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2063-2069

2007

Volltextzugriff (PDF)

Clinical implications of FLT3 mutations in pediatric AML

Blood, 2006-12, Vol.108 (12), p.3654-3661

2006

Volltextzugriff (PDF)

Differences in Outcomes of Newly Diagnosed Acute Myeloid Leukemia for Adolescent/Young Adult and Younger Patients: A Report from the Children's Oncology Group

Cancer, 2013-12, Vol.119 (23), p.4162-4169

2013

Volltextzugriff (PDF)

A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma

Frontiers in oncology, 2021-09, Vol.11, p.744739-744739

2021

Volltextzugriff (PDF)

Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5797-5801

2008

Volltextzugriff (PDF)

Mortality in overweight and underweight children with acute myeloid leukemia

JAMA : the journal of the American Medical Association, 2005-01, Vol.293 (2), p.203

2005

Volltextzugriff (PDF)

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

The lancet oncology, 2008-09, Vol.9 (9), p.873-883

2008

Volltextzugriff (PDF)

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Blood, 2009-06, Vol.113 (26), p.6558-6566

2009

Volltextzugriff (PDF)

Structural and numerical variation of FLT3/ITD in pediatric AML

Blood, 2008-05, Vol.111 (10), p.4930-4933

2008

Volltextzugriff (PDF)

Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology Group

Pediatric blood & cancer, 2012-04, Vol.58 (4), p.519-524

2012

Volltextzugriff (PDF)

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Blood, 2011-06, Vol.117 (26), p.7007-7013

2011

Volltextzugriff (PDF)

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report

Blood, 2013-02, Vol.121 (7), p.1083-1093

2013

Volltextzugriff (PDF)

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Blood, 2010-08, Vol.116 (5), p.702-710

2010

Volltextzugriff (PDF)

Robert J. Arceci, MD, PhD, 1950-2015

Pediatric blood & cancer, 2015-08, Vol.62 (8), p.i-ii

2015

Volltextzugriff (PDF)

Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2390-2395

2008

Volltextzugriff (PDF)

Central nervous system juvenile xanthogranuloma with malignant transformation

Pediatric Blood & Cancer, 2008-04, Vol.50 (4), p.927-930

2008

Volltextzugriff (PDF)

T(11q23): brand necessary

Blood, 2009-09, Vol.114 (12), p.2365-2366

Lange, Beverly J.

2009

Volltextzugriff (PDF)

Effects of physical therapy intervention for children with acute lymphoblastic leukemia

Pediatric Blood & Cancer, 2004-02, Vol.42 (2), p.127-133

2004

Volltextzugriff (PDF)

WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2011-02, Vol.29 (6), p.704-711

2011

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Englisch
(335)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Humans
(229)
Science & Technology
(219)
Life Sciences & Biomedicine
(210)
Child
(171)
Male
(153)
Female
(152)
Biological And Medical Sciences
(151)
Medical Sciences
(146)
Child, Preschool
(132)
Adolescent
(115)
Oncology
(111)
Infant
(101)
Hematology
(92)
Hematologic And Hematopoietic Diseases
(84)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(80)
Adult
(69)
Pediatrics
(58)
Treatment Outcome
(49)
Prognosis
(44)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Clinical implications of FLT3 mutations in pediatric AML

Differences in Outcomes of Newly Diagnosed Acute Myeloid Leukemia for Adolescent/Young Adult and Younger Patients: A Report from the Children's Oncology Group

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML

A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma

Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group

Mortality in overweight and underweight children with acute myeloid leukemia

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Structural and numerical variation of FLT3/ITD in pediatric AML

Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology Group

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Robert J. Arceci, MD, PhD, 1950-2015

Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group

Central nervous system juvenile xanthogranuloma with malignant transformation

T(11q23): brand necessary

Effects of physical therapy intervention for children with acute lymphoblastic leukemia

WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Suchergebnisse filtern